Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Promaxo, Inc.

Promaxo, Inc.

Stage unknownOakland, CApromaxo.comBiotechnology

Promaxo is the FDA-cleared point-of-care MRI platform for prostate interventions.

Facts
Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
3
Financing history
1 rounds
  1. Mar 25, 2024
    Form D equity offering · $31.6M (form d sold) · 104 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Promaxo, Inc. filed Form D: $31,606,277 sold of $36,838,350, Biotechnology”
Investors on record
3 edges
People
3 officers, 4 directors
Timeline
2
  1. Jul 10, 2024
    Promaxo, Inc. filed Form D/A: $41,939,728 sold of $57,304,100, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  2. Apr 8, 2024
    Promaxo, Inc. filed Form D: $31,606,277 sold of $36,838,350, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
37 observations
Every observation on this company